Barclays
AVNS

Barclays’s Avanos Medical AVNS Stock Holding History

Barclays’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39,900
Closed -$2.28M – 7105
2018
Q2 		$2.28M Buy
+39,900
New +$2.11M ﹤0.01% 2456
2016
Q1 		– Sell
-72
Closed -$2K – 6131
2015
Q4 		$2K Sell
72
-60
-45% -$1.87K ﹤0.01% 5737
2015
Q3 		$4K Hold
132
– – ﹤0.01% 6102
2015
Q2 		$5K Sell
132
-108
-45% -$4.85K ﹤0.01% 6425
2015
Q1 		$12K Sell
240
-1,680
-88% -$77.8K ﹤0.01% 6104
2014
Q4 		$86K Buy
+1,920
New +$75.4K ﹤0.01% 5322

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Barclays's AVNS Position: Q1 2026 in Review

Barclays reduced its Avanos Medical (AVNS) stake by 80% in Q1 2026, selling an estimated $757K and leaving 13,786 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3711.

Barclays first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.7M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Barclays held 13,786 shares of Avanos Medical worth $193K as of Q1 2026.
  • Barclays sold 56,152 Avanos Medical shares in Q1 2026, an estimated $757K.
  • Avanos Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3711 holding.
  • Barclays first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
  • Barclays's Avanos Medical position peaked at $5.7M in Q3 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.